Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement

Rony Dahan(Rockefeller University), Bryan C. Barnhart(Bristol-Myers Squibb (United States)), Fubin Li(Rockefeller University), Aaron P. Yamniuk(Bristol-Myers Squibb (United States)), Alan J. Korman(Bristol-Myers Squibb (United States)), Jeffrey V. Ravetch(Rockefeller University)
Cancer Cell
June 1, 2016
10.1016/j.ccell.2016.05.001
Cited by 167Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis